» Articles » PMID: 37275275

Estrogen Receptor Alpha Mutations Regulate Gene Expression and Cell Growth in Breast Cancer Through MicroRNAs

Overview
Journal NAR Cancer
Specialty Oncology
Date 2023 Jun 5
PMID 37275275
Authors
Affiliations
Soon will be listed here.
Abstract

Estrogen receptor α (ER) mutations occur in up to 30% of metastatic ER-positive breast cancers. Recent data has shown that ER mutations impact the expression of thousands of genes not typically regulated by wildtype ER. While the majority of these altered genes can be explained by constant activity of mutant ER or genomic changes such as altered ER binding and chromatin accessibility, as much as 33% remain unexplained, indicating the potential for post-transcriptional effects. Here, we explored the role of microRNAs in mutant ER-driven gene regulation and identified several microRNAs that are dysregulated in ER mutant cells. These differentially regulated microRNAs target a significant portion of mutant-specific genes involved in key cellular processes. When the activity of microRNAs is altered using mimics or inhibitors, significant changes are observed in gene expression and cellular proliferation related to mutant ER. An in-depth evaluation of miR-301b led us to discover an important role for in the proliferation of ER mutant cells. Our findings show that microRNAs contribute to mutant ER gene regulation and cellular effects in breast cancer cells.

Citing Articles

Estrogen Receptor Alpha Mutations, Truncations, Heterodimers, and Therapies.

Hancock G, Gertz J, Jeselsohn R, Fanning S Endocrinology. 2024; 165(6).

PMID: 38643482 PMC: 11075793. DOI: 10.1210/endocr/bqae051.


MicroRNA-Based Discovery of Biomarkers, Therapeutic Targets, and Repositioning Drugs for Breast Cancer.

Ye Q, Raese R, Luo D, Feng J, Xin W, Dong C Cells. 2023; 12(14).

PMID: 37508580 PMC: 10378316. DOI: 10.3390/cells12141917.

References
1.
Liu Y, Song H, Yu S, Huang K, Ma X, Zhou Y . Protein Kinase D3 promotes the cell proliferation by activating the ERK1/c-MYC axis in breast cancer. J Cell Mol Med. 2020; 24(3):2135-2144. PMC: 7011155. DOI: 10.1111/jcmm.14772. View

2.
Weis K, Ekena K, Thomas J, Lazennec G, Katzenellenbogen B . Constitutively active human estrogen receptors containing amino acid substitutions for tyrosine 537 in the receptor protein. Mol Endocrinol. 1996; 10(11):1388-98. DOI: 10.1210/mend.10.11.8923465. View

3.
Blanchard Z, Rush C, Arnesen S, Vahrenkamp J, Rodriguez A, Jarboe E . Allele-Specific Gene Regulation, Phenotypes, and Therapeutic Vulnerabilities in Estrogen Receptor Alpha-Mutant Endometrial Cancer. Mol Cancer Res. 2023; 21(10):1023-1036. DOI: 10.1158/1541-7786.MCR-22-0848. View

4.
Kondo N, Toyama T, Sugiura H, Fujii Y, Yamashita H . miR-206 Expression is down-regulated in estrogen receptor alpha-positive human breast cancer. Cancer Res. 2008; 68(13):5004-8. DOI: 10.1158/0008-5472.CAN-08-0180. View

5.
Borras M, Hardy L, Lempereur F, el Khissiin A, Legros N, Leclercq G . Estradiol-induced down-regulation of estrogen receptor. Effect of various modulators of protein synthesis and expression. J Steroid Biochem Mol Biol. 1994; 48(4):325-36. DOI: 10.1016/0960-0760(94)90072-8. View